Indo Amines Limited

NSEI:INDOAMIN Stock Report

Market Cap: ₹12.1b

Indo Amines Past Earnings Performance

Past criteria checks 2/6

Indo Amines has been growing earnings at an average annual rate of 21.3%, while the Chemicals industry saw earnings growing at 14.6% annually. Revenues have been growing at an average rate of 16.9% per year. Indo Amines's return on equity is 17.7%, and it has net margins of 5.3%.

Key information

21.3%

Earnings growth rate

20.8%

EPS growth rate

Chemicals Industry Growth17.7%
Revenue growth rate16.9%
Return on equity17.7%
Net Margin5.3%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

There's Reason For Concern Over Indo Amines Limited's (NSE:INDOAMIN) Massive 32% Price Jump

Sep 26
There's Reason For Concern Over Indo Amines Limited's (NSE:INDOAMIN) Massive 32% Price Jump

Indo Amines (NSE:INDOAMIN) Is Due To Pay A Dividend Of ₹0.50

Sep 17
Indo Amines (NSE:INDOAMIN) Is Due To Pay A Dividend Of ₹0.50

Indo Amines (NSE:INDOAMIN) Is Paying Out A Dividend Of ₹0.50

Sep 03
Indo Amines (NSE:INDOAMIN) Is Paying Out A Dividend Of ₹0.50

Indo Amines Limited (NSE:INDOAMIN) Shares Fly 30% But Investors Aren't Buying For Growth

Aug 12
Indo Amines Limited (NSE:INDOAMIN) Shares Fly 30% But Investors Aren't Buying For Growth

Indo Amines (NSE:INDOAMIN) Has Affirmed Its Dividend Of ₹0.50

Aug 11
Indo Amines (NSE:INDOAMIN) Has Affirmed Its Dividend Of ₹0.50

Here's Why Indo Amines (NSE:INDOAMIN) Has A Meaningful Debt Burden

Aug 07
Here's Why Indo Amines (NSE:INDOAMIN) Has A Meaningful Debt Burden

Does Indo Amines (NSE:INDOAMIN) Deserve A Spot On Your Watchlist?

Jul 17
Does Indo Amines (NSE:INDOAMIN) Deserve A Spot On Your Watchlist?

Indo Amines Limited's (NSE:INDOAMIN) Earnings Are Not Doing Enough For Some Investors

Jun 28
Indo Amines Limited's (NSE:INDOAMIN) Earnings Are Not Doing Enough For Some Investors

Indo Amines Limited (NSE:INDOAMIN) Might Not Be As Mispriced As It Looks After Plunging 25%

Mar 09
Indo Amines Limited (NSE:INDOAMIN) Might Not Be As Mispriced As It Looks After Plunging 25%

Does Indo Amines (NSE:INDOAMIN) Have A Healthy Balance Sheet?

Feb 18
Does Indo Amines (NSE:INDOAMIN) Have A Healthy Balance Sheet?

Should You Be Adding Indo Amines (NSE:INDOAMIN) To Your Watchlist Today?

Jan 31
Should You Be Adding Indo Amines (NSE:INDOAMIN) To Your Watchlist Today?

Even With A 33% Surge, Cautious Investors Are Not Rewarding Indo Amines Limited's (NSE:INDOAMIN) Performance Completely

Jan 03
Even With A 33% Surge, Cautious Investors Are Not Rewarding Indo Amines Limited's (NSE:INDOAMIN) Performance Completely

A Look Into Indo Amines' (NSE:INDOAMIN) Impressive Returns On Capital

Dec 07
A Look Into Indo Amines' (NSE:INDOAMIN) Impressive Returns On Capital

Pinning Down Indo Amines Limited's (NSE:INDOAMIN) P/E Is Difficult Right Now

Jun 14
Pinning Down Indo Amines Limited's (NSE:INDOAMIN) P/E Is Difficult Right Now

Revenue & Expenses Breakdown

How Indo Amines makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NSEI:INDOAMIN Revenue, expenses and earnings (INR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 249,8135165150
30 Jun 249,6505004740
31 Mar 249,4364264630
31 Dec 239,2505044430
30 Sep 239,4225124330
30 Jun 239,3044453990
31 Mar 239,4504043990
31 Dec 229,2422603690
30 Sep 229,2472533560
30 Jun 228,6722443400
31 Mar 227,8602303330
31 Dec 217,2853683200
30 Sep 216,5923953120
30 Jun 216,1234193120
31 Mar 215,4053752910
31 Dec 205,0702293040
30 Sep 204,7861282990
30 Jun 204,5381082710
31 Mar 204,7871282970
31 Dec 194,9471812880
30 Sep 195,0512382760
30 Jun 195,1462522680
31 Mar 195,2812522710
31 Mar 183,5531601830
31 Mar 172,8451621500
31 Mar 162,526911250
31 Dec 152,426972895
30 Sep 152,413882825
30 Jun 152,383672815
31 Mar 152,340531130
31 Dec 142,364381450
30 Sep 142,466531970
30 Jun 142,329601850
31 Mar 142,206582684
31 Dec 132,114551610

Quality Earnings: INDOAMIN has high quality earnings.

Growing Profit Margin: INDOAMIN's current net profit margins (5.3%) are lower than last year (5.4%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: INDOAMIN's earnings have grown significantly by 21.3% per year over the past 5 years.

Accelerating Growth: INDOAMIN's earnings growth over the past year (0.9%) is below its 5-year average (21.3% per year).

Earnings vs Industry: INDOAMIN earnings growth over the past year (0.9%) did not outperform the Chemicals industry 8%.


Return on Equity

High ROE: INDOAMIN's Return on Equity (17.7%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies